Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Psychogenic non-epileptic seizures with comorbid epilepsy: insights from patient and caregiver characteristics
Epilepsy/Clinical Neurophysiology (EEG)
Epilepsy/Clinical Neurophysiology (EEG) Posters (7:00 AM-5:00 PM)
041

We used a well-characterized group of patients with epileptic seizures (ES), psychogenic non-epileptic seizures (PNES), and PNES with comorbid epilepsy (ES+PNES), along with their caregivers, to investigate potential differences among the three populations in terms of demographic, clinical, and psychosocial characteristics.

ES+PNES coexist in approximately 6-10% of patients admitted to the Epilepsy Monitoring Unit (EMU). Despite their substantial prevalence and high complexity, little is known about families living with ES+PNES.

Patients admitted to the Emory University Hospital EMU from September 2016 and June 2019 along with their caregivers completed questionnaires on demographic, clinical, and psychosocial aspects of their disease before their diagnosis was elucidated. Using video-EEG as gold standard, the cohort was trichotomized as ES, PNES, and ES+PNES. Univariate analysis was used to evaluate differences in all collected characteristics between the 3 populations. 

43 PNES, 165 ES, and 22 ES+PNES patients were recruited. Compared to ES and PNES, ES+PNES patients had longer disease duration. PNES patients had the highest rate of spell frequency per month. ES patients had fewer comorbidities, greater number of antiseizure medications, fewer medication side effects, fewer hospital admissions for seizures, better quality of life, less perceived stigma, worse epilepsy knowledge, and less anxiety and depression compared to PNES and ES+PNES patients. Additionally, 28 PNES, 99 ES, and 10 ES+PNES caregivers were recruited. There were no statistically significant differences among caregivers, except ES+PNES caregivers were predominantly male, while ES and PNES caregivers were mostly female.

PNES and ES+PNES patients exhibited more anxiety and depression and worse overall quality of life compared to ES patients. This suggests that the PNES psychosocial phenotype may dominate in ES+PNES patients. Future studies investigating larger cohorts are warranted to corroborate these findings and identify targets for intervention trials to assist these patients and families. 
Authors/Disclosures
Aida Risman, MD (Emory Brain Health Center, Neurology)
PRESENTER
Dr. Risman has nothing to disclose.
Nicholas Janocko, MD (Weill Cornell Neurology) Dr. Janocko has nothing to disclose.
Ndubuisi Ahuruonye, MD Dr. Ahuruonye has nothing to disclose.
Matthew L. Morton, MD (Piedmont Atlanta Hospital) Dr. Morton has nothing to disclose.
Olivia Groover, MD Dr. Groover has nothing to disclose.
Diane Teagarden, NP Ms. Teagarden has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for livaNova. Ms. Teagarden has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace.
No disclosure on file
Daniel Drane, PhD (Emory University School of Medicine) Dr. Drane has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Medical Directors Solutions, Inc. The institution of Dr. Drane has received research support from NIH/NINDS. The institution of Dr. Drane has received research support from Medtronic, Inc..
David W. Loring, PhD, FÂé¶¹´«Ã½Ó³»­ Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE. The institution of Dr. Loring has received research support from NIH. Dr. Loring has received publishing royalties from a publication relating to health care.
Rebecca E. Matthews, MD (Emory University) Dr. Matthews has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Penry Epilepsy Programs.
Ioannis Karakis, MD, FÂé¶¹´«Ã½Ó³»­ (Emory University) Dr. Karakis has received personal compensation for serving as an employee of Emory University School of Medicine. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Karakis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GSK. Dr. Karakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epitel. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hill Ward Henderson.